Title:
MODIFICATION OF ENGINEERED INFLUENZA HEMAGGLUTININ POLYPEPTIDES
Document Type and Number:
Japanese Patent JP2022153591
Kind Code:
A
Abstract:
To provide modification of engineered influenza hemagglutinin polypeptides.SOLUTION: The present invention provides, among other things, modified recombinant HA polypeptides with broadened immunogenic profiles that extend coverage to antigenically distinct influenza strains, and methods of making and using the same.SELECTED DRAWING: Figure 1
Inventors:
Todd Stragnell
Eliud Oroo
raymond omen
Eliud Oroo
raymond omen
Application Number:
JP2022122751A
Publication Date:
October 12, 2022
Filing Date:
August 01, 2022
Export Citation:
Assignee:
Sanofi Pasteur Incorporated
International Classes:
A61K39/145; A61P31/16; C07K14/11; C07K19/00; C12N15/44; C12N15/62
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto